nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—MAOA—conduct disorder	0.902	1	CbGaD
Moclobemide—MAOB—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOA—conduct disorder	0.02	0.221	CbGpPWpGaD
Moclobemide—MAOA—Enzymatic degradation of Dopamine by monoamine oxidase—COMT—conduct disorder	0.0126	0.14	CbGpPWpGaD
Moclobemide—MAOB—Amine Oxidase reactions—MAOA—conduct disorder	0.0115	0.127	CbGpPWpGaD
Moclobemide—MAOA—Clearance of dopamine—COMT—conduct disorder	0.00914	0.101	CbGpPWpGaD
Moclobemide—MAOB—Dopamine metabolism—COMT—conduct disorder	0.00451	0.0498	CbGpPWpGaD
Moclobemide—MAOB—Dopamine metabolism—MAOA—conduct disorder	0.00447	0.0495	CbGpPWpGaD
Moclobemide—MAOA—Serotonin Transporter Activity—SLC6A4—conduct disorder	0.00427	0.0472	CbGpPWpGaD
Moclobemide—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00417	0.0461	CbGpPWpGaD
Moclobemide—MAOA—Dopamine metabolism—COMT—conduct disorder	0.00283	0.0313	CbGpPWpGaD
Moclobemide—MAOA—Biogenic Amine Synthesis—COMT—conduct disorder	0.00252	0.0279	CbGpPWpGaD
Moclobemide—Minaprine—MAOA—conduct disorder	0.00252	0.347	CrCbGaD
Moclobemide—Minaprine—SLC6A4—conduct disorder	0.00162	0.224	CrCbGaD
Moclobemide—CYP1A2—Methylation—COMT—conduct disorder	0.00129	0.0142	CbGpPWpGaD
Moclobemide—Haloperidol—DRD4—conduct disorder	0.00128	0.176	CrCbGaD
Moclobemide—Minaprine—HTR2A—conduct disorder	0.00125	0.172	CrCbGaD
Moclobemide—MAOB—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00107	0.0118	CbGpPWpGaD
Moclobemide—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.000804	0.00889	CbGpPWpGaD
Moclobemide—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0007	0.00773	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00066	0.00729	CbGpPWpGaD
Moclobemide—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000643	0.00711	CbGpPWpGaD
Moclobemide—Haloperidol—HTR2A—conduct disorder	0.00059	0.0813	CrCbGaD
Moclobemide—MAOB—Biological oxidations—COMT—conduct disorder	0.000571	0.00631	CbGpPWpGaD
Moclobemide—MAOB—Biological oxidations—MAOA—conduct disorder	0.000567	0.00627	CbGpPWpGaD
Moclobemide—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.000545	0.00603	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000511	0.00565	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—GABRA2—conduct disorder	0.000505	0.00559	CbGpPWpGaD
Moclobemide—MAOA—Biological oxidations—COMT—conduct disorder	0.000358	0.00396	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—COMT—conduct disorder	0.000318	0.00351	CbGpPWpGaD
Moclobemide—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000317	0.0035	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000314	0.00347	CbGpPWpGaD
Moclobemide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000292	0.00322	CbGpPWpGaD
Moclobemide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000289	0.0032	CbGpPWpGaD
Moclobemide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000247	0.00273	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—COMT—conduct disorder	0.000243	0.00269	CbGpPWpGaD
Moclobemide—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000226	0.0025	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CGA—conduct disorder	0.000216	0.00239	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00017	0.00188	CbGpPWpGaD
Moclobemide—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000168	0.00186	CbGpPWpGaD
Moclobemide—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000167	0.00185	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000166	0.00184	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000163	0.0018	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000163	0.0018	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000156	0.00172	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000155	0.00171	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000155	0.00171	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000154	0.0017	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000154	0.0017	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000153	0.00169	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000144	0.0016	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CGA—conduct disorder	0.000136	0.0015	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000132	0.00146	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000132	0.00145	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000131	0.00145	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00013	0.00144	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000112	0.00124	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—COMT—conduct disorder	9.76e-05	0.00108	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—MAOA—conduct disorder	9.7e-05	0.00107	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CGA—conduct disorder	6.42e-05	0.00071	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—COMT—conduct disorder	6.13e-05	0.000677	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CGA—conduct disorder	5.91e-05	0.000653	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CGA—conduct disorder	5.86e-05	0.000648	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CGA—conduct disorder	5.01e-05	0.000553	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—EP300—conduct disorder	4.19e-05	0.000463	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—COMT—conduct disorder	2.9e-05	0.000321	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MAOA—conduct disorder	2.88e-05	0.000318	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.79e-05	0.000309	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—COMT—conduct disorder	2.67e-05	0.000295	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MAOA—conduct disorder	2.65e-05	0.000293	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—COMT—conduct disorder	2.64e-05	0.000292	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—EP300—conduct disorder	2.63e-05	0.000291	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MAOA—conduct disorder	2.63e-05	0.00029	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.55e-05	0.000282	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—COMT—conduct disorder	2.26e-05	0.00025	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MAOA—conduct disorder	2.24e-05	0.000248	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.18e-05	0.000241	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—EP300—conduct disorder	1.24e-05	0.000138	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—EP300—conduct disorder	1.14e-05	0.000126	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—EP300—conduct disorder	1.13e-05	0.000125	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—EP300—conduct disorder	9.69e-06	0.000107	CbGpPWpGaD
